210 related articles for article (PubMed ID: 18619574)
1. The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways: an in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms.
Kot M; Daniel WA
Biochem Pharmacol; 2008 Aug; 76(4):543-51. PubMed ID: 18619574
[TBL] [Abstract][Full Text] [Related]
2. Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: the pathway and concentration dependence.
Kot M; Daniel WA
Biochem Pharmacol; 2008 Apr; 75(7):1538-49. PubMed ID: 18279840
[TBL] [Abstract][Full Text] [Related]
3. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
4. Caffeine as a marker substrate for testing cytochrome P450 activity in human and rat.
Kot M; Daniel WA
Pharmacol Rep; 2008; 60(6):789-97. PubMed ID: 19211970
[TBL] [Abstract][Full Text] [Related]
5. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
[TBL] [Abstract][Full Text] [Related]
6. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.
Wang RW; Liu L; Cheng H
Drug Metab Dispos; 1996 Jul; 24(7):786-91. PubMed ID: 8818577
[TBL] [Abstract][Full Text] [Related]
7. Effect of cytochrome P450 (CYP) inducers on caffeine metabolism in the rat.
Kot M; Daniel WA
Pharmacol Rep; 2007; 59(3):296-305. PubMed ID: 17652830
[TBL] [Abstract][Full Text] [Related]
8. Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine.
Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
Br J Pharmacol; 2003 Apr; 138(8):1465-74. PubMed ID: 12721102
[TBL] [Abstract][Full Text] [Related]
9. Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism--an in vitro study.
Wójcikowski J; Daniel WA
Pharmacol Rep; 2009; 61(5):851-8. PubMed ID: 19904008
[TBL] [Abstract][Full Text] [Related]
10. Effect of diethyldithiocarbamate (DDC) and ticlopidine on CYP1A2 activity and caffeine metabolism: an in vitro comparative study with human cDNA-expressed CYP1A2 and liver microsomes.
Kot M; Daniel WA
Pharmacol Rep; 2009; 61(6):1216-20. PubMed ID: 20081260
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine.
Tugnait M; Hawes EM; McKay G; Eichelbaum M; Midha KK
Chem Biol Interact; 1999 Apr; 118(2):171-89. PubMed ID: 10359460
[TBL] [Abstract][Full Text] [Related]
12. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100
[TBL] [Abstract][Full Text] [Related]
13. Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms.
Tassaneeyakul W; Birkett DJ; McManus ME; Tassaneeyakul W; Veronese ME; Andersson T; Tukey RH; Miners JO
Biochem Pharmacol; 1994 May; 47(10):1767-76. PubMed ID: 8204093
[TBL] [Abstract][Full Text] [Related]
14. Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs.
Nakajima M; Nakamura S; Tokudome S; Shimada N; Yamazaki H; Yokoi T
Drug Metab Dispos; 1999 Dec; 27(12):1381-91. PubMed ID: 10570018
[TBL] [Abstract][Full Text] [Related]
15. Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes.
Kobayashi K; Chiba K; Yagi T; Shimada N; Taniguchi T; Horie T; Tani M; Yamamoto T; Ishizaki T; Kuroiwa Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):927-33. PubMed ID: 9023308
[TBL] [Abstract][Full Text] [Related]
16. Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes.
Kim KA; Chung J; Jung DH; Park JY
Eur J Clin Pharmacol; 2004 Oct; 60(8):575-81. PubMed ID: 15365656
[TBL] [Abstract][Full Text] [Related]
17. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.
Kazui M; Nishiya Y; Ishizuka T; Hagihara K; Farid NA; Okazaki O; Ikeda T; Kurihara A
Drug Metab Dispos; 2010 Jan; 38(1):92-9. PubMed ID: 19812348
[TBL] [Abstract][Full Text] [Related]
18. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
[TBL] [Abstract][Full Text] [Related]
20. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.
Zhang WV; D'Esposito F; Edwards RJ; Ramzan I; Murray M
Drug Metab Dispos; 2008 Dec; 36(12):2547-55. PubMed ID: 18809730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]